Shenzhen Salubris Pharmaceuticals Dividend
Dividend criteriumcontroles 2/6
Shenzhen Salubris Pharmaceuticals is a dividend paying company with a current yield of 1.5%.
Belangrijke informatie
1.5%
Dividendrendement
0.7%
Terugkoop Rendement
| Totaal aandeelhoudersrendement | 2.2% |
| Toekomstig dividendrendement | 1.5% |
| Dividendgroei | -6.8% |
| Volgende betaaldatum dividend | n/a |
| Ex-dividenddatum | n/a |
| Dividend per aandeel | CN¥0.500 |
| Uitbetalingsratio | 91% |
Recente dividendupdates
Recent updates
We Think That There Are More Issues For Shenzhen Salubris Pharmaceuticals (SZSE:002294) Than Just Sluggish Earnings
Sep 02
What Shenzhen Salubris Pharmaceuticals Co., Ltd.'s (SZSE:002294) P/E Is Not Telling You
Aug 23Are Investors Undervaluing Shenzhen Salubris Pharmaceuticals Co., Ltd. (SZSE:002294) By 21%?
Aug 02Shenzhen Salubris Pharmaceuticals Co., Ltd.'s (SZSE:002294) Share Price Not Quite Adding Up
May 22A Look At The Fair Value Of Shenzhen Salubris Pharmaceuticals Co., Ltd. (SZSE:002294)
Apr 17Is Shenzhen Salubris Pharmaceuticals (SZSE:002294) A Risky Investment?
Feb 28Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: 002294's dividend payments have been volatile in the past 10 years.
Groeiend dividend: 002294's dividend payments have increased over the past 10 years.
Dividendrendement versus markt
| Shenzhen Salubris Pharmaceuticals Dividendrendement versus markt |
|---|
| Segment | Dividendrendement |
|---|---|
| Bedrijf (002294) | 1.5% |
| Markt onderkant 25% (CN) | 0.6% |
| Markt Top 25% (CN) | 2.2% |
| Gemiddelde industrie (Pharmaceuticals) | 1.7% |
| Analist prognose (002294) (tot 3 jaar) | 1.5% |
Opmerkelijk dividend: 002294's dividend (1.5%) is higher than the bottom 25% of dividend payers in the CN market (0.57%).
Hoog dividend: 002294's dividend (1.5%) is low compared to the top 25% of dividend payers in the CN market (2.22%).
Winstuitkering aan aandeelhouders
Verdiendekking: With its high payout ratio (91%), 002294's dividend payments are not well covered by earnings.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: With its high cash payout ratio (99.3%), 002294's dividend payments are not well covered by cash flows.